Trupanion Inc (NYSE:TRUP) Director Howard E. Rubin sold 21,249 shares of the stock in a transaction that occurred on Wednesday, November 23rd. The stock was sold at an average price of $17.01, for a total transaction of $361,445.49. Following the completion of the transaction, the director now owns 41,294 shares in the company, valued at $702,410.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Trupanion Inc (NYSE:TRUP) traded down 1.41% during trading on Wednesday, reaching $16.75. 91,550 shares of the company traded hands. Trupanion Inc has a 52 week low of $7.61 and a 52 week high of $17.68. The company’s market capitalization is $489.99 million. The firm has a 50-day moving average price of $16.12 and a 200-day moving average price of $15.19.

Trupanion (NYSE:TRUP) last announced its quarterly earnings data on Tuesday, November 1st. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.06). The firm earned $48.40 million during the quarter, compared to analysts’ expectations of $48.17 million. During the same period in the prior year, the company posted ($0.17) EPS. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. Analysts forecast that Trupanion Inc will post ($0.23) earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Trupanion (NYSE:TRUP)

Several large investors have recently made changes to their positions in TRUP. AQR Capital Management LLC purchased a new stake in shares of Trupanion during the second quarter worth about $146,000. BlackRock Advisors LLC boosted its position in Trupanion by 88.0% in the third quarter. BlackRock Advisors LLC now owns 8,616 shares of the company’s stock worth $146,000 after buying an additional 4,032 shares during the last quarter. Metropolitan Life Insurance Co. NY bought a new position in Trupanion during the second quarter worth approximately $160,000. A.R.T. Advisors LLC bought a new position in Trupanion during the second quarter worth approximately $166,000. Finally, Alliancebernstein L.P. bought a new position in Trupanion during the second quarter worth approximately $168,000.

Several research analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Wednesday, July 27th. Stifel Nicolaus increased their price target on shares of Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. RBC Capital Markets set a $18.00 price target on shares of Trupanion and gave the stock a “buy” rating in a research report on Tuesday, September 20th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $19.00 price target on shares of Trupanion in a research report on Thursday, August 4th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $16.00.

WARNING: This piece of content was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/23/trupanion-inc-trup-director-howard-e-rubin-sells-21249-shares.html.

Trupanion Company Profile

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

5 Day Chart for NYSE:TRUP

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.